While we wait for SleepCheck's data, here are the data for the Monash Fodmap app taken from
https://www.monash.edu/about/who/publications/annual-report. Looks like in the past few years, they're earning around $1m a year with < 100k new users a year. Now we just need to beat them in the app store.
2015:Our FODMAP Diet app was the number one medical app in more than 50 countries, being used by more than 100,000 people worldwide. So far, the app has raised over $1 million in sales, which will be used to support further research.
2016:Monash University’s FODMAP DietTM application for smartphones and tablets remained the number one medical application for over two years, being actively used by over 100,000 people to manage irritable bowel syndrome symptoms. The application raised approximately $2 million in sales, enabling the support of further research
2017:Monash University’s FODMAP Diet application for smartphones and tablets remained the number one medical app for most of the last three years, being used by more than 200,000 people globally to manage irritable bowel syndrome. By the end of 2017 the app had raised approximately $2.7 million in sales, enabling support of further research;
2018:Monash University’s FODMAP Diet app for smartphones and tablets remained the number one medical app for most of the last four years, used by over 400,000 people globally to manage irritable bowel syndrome. It has raised over $4 million in sales and is expanding internationally as well as developing a food certification scheme
2019:Remained the No.1 medical app, used by more than 400,000 people globally to manage irritable bowel syndrome (IBS). With sales exceeding $5 million, it’s expanding internationally, and has established a food certification scheme. It’s been listed in the American College of Gastroenterology Clinical Practice Guidelines for IBS treatmenthttps://www.monash.edu/about/who/publications/annual-report
